PL3515413T3 - Postać dawkowania zapewniająca przedłużoną ulgę - Google Patents
Postać dawkowania zapewniająca przedłużoną ulgęInfo
- Publication number
- PL3515413T3 PL3515413T3 PL17778156.4T PL17778156T PL3515413T3 PL 3515413 T3 PL3515413 T3 PL 3515413T3 PL 17778156 T PL17778156 T PL 17778156T PL 3515413 T3 PL3515413 T3 PL 3515413T3
- Authority
- PL
- Poland
- Prior art keywords
- dosage form
- prolonged relief
- relief
- prolonged
- dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662399511P | 2016-09-26 | 2016-09-26 | |
| PCT/US2017/053157 WO2018058009A1 (en) | 2016-09-26 | 2017-09-25 | Extended relief dosage form |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3515413T3 true PL3515413T3 (pl) | 2023-11-13 |
Family
ID=60002143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17778156.4T PL3515413T3 (pl) | 2016-09-26 | 2017-09-25 | Postać dawkowania zapewniająca przedłużoną ulgę |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10576041B2 (pl) |
| EP (1) | EP3515413B1 (pl) |
| CN (1) | CN109789101A (pl) |
| AU (1) | AU2017331369B2 (pl) |
| BR (1) | BR112019005224A2 (pl) |
| CA (1) | CA3038263C (pl) |
| MX (1) | MX385881B (pl) |
| PL (1) | PL3515413T3 (pl) |
| RU (1) | RU2019109695A (pl) |
| WO (1) | WO2018058009A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201506755D0 (en) | 2015-04-21 | 2015-06-03 | Reckitt Benckiser Llc | Novel pharmaceutical formulation |
| US11278506B2 (en) | 2015-10-09 | 2022-03-22 | Rb Health (Us) Llc | Pharmaceutical formulation |
| CA3038263C (en) | 2016-09-26 | 2022-04-05 | The Procter & Gamble Company | Extended relief dosage form |
| CN117885446A (zh) | 2018-06-26 | 2024-04-16 | 兰达公司 | 数字印刷系统的中间传输构件 |
| CA3201462A1 (en) * | 2020-11-13 | 2022-05-19 | Bayer Healthcare Llc | Oral bilayer tablets comprising acetylsalicylic acid and pseudoephedrine, methods of preparing and using thereof |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4552899A (en) | 1984-04-09 | 1985-11-12 | Analgesic Associates | Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
| ES2179075T3 (es) * | 1993-06-04 | 2003-01-16 | Warner Lambert Co | Preparaciones que contienen dioxido de silicio para mejorar su sabor. |
| EP0719156A1 (en) | 1993-09-07 | 1996-07-03 | The Procter & Gamble Company | Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive |
| US5859060A (en) | 1997-01-15 | 1999-01-12 | Platt; Chris | Timed release tablet comprising naproxen and pseudoepherine |
| US6132758A (en) | 1998-06-01 | 2000-10-17 | Schering Corporation | Stabilized antihistamine syrup |
| EP1107740A4 (en) * | 1998-08-25 | 2002-03-06 | Platt Chris | SLOW RELEASE TABLET COMPRISING NAPROXENE AND PSEUDOEPHEDRINE |
| SK287105B6 (sk) | 1999-12-20 | 2009-12-07 | Schering Corporation | Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním |
| BR0212951A (pt) | 2001-09-28 | 2004-10-26 | Mcneil Ppc Inc | Formas de dosagens compósitas |
| US6753009B2 (en) | 2002-03-13 | 2004-06-22 | Mcneil-Ppc, Inc. | Soft tablet containing high molecular weight polyethylene oxide |
| TWI313598B (en) | 2002-12-18 | 2009-08-21 | Wyeth Corp | Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines |
| CA2549195A1 (en) * | 2003-12-09 | 2005-06-23 | Spherics, Inc. | Bioadhesive polymers with catechol functionality |
| US20050266032A1 (en) * | 2003-12-17 | 2005-12-01 | Sovereign Pharmaceuticals, Ltd. | Dosage form containing multiple drugs |
| US20050249802A1 (en) | 2004-05-06 | 2005-11-10 | The Procter & Gamble Company | Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients |
| DE102004045037A1 (de) | 2004-09-15 | 2006-03-16 | Basf Ag | Pharmazeutische Darreichungsformen mit erschwerter Extrahierbarkeit eines Sympathomimetikums aus der Darreichungsform |
| US20070148238A1 (en) * | 2005-06-23 | 2007-06-28 | Spherics, Inc. | Dosage forms for movement disorder treatment |
| WO2007072503A2 (en) | 2005-12-21 | 2007-06-28 | Panacea Biotec Ltd. | Combinations for managing inflammation and associated disorders |
| WO2007141743A2 (en) * | 2006-06-06 | 2007-12-13 | Ranbaxy Laboratories Limited | A tablet dosage form comprising cetirizine and pseudoephedrine |
| US20080014274A1 (en) | 2006-07-14 | 2008-01-17 | Wyeth | Enhanced stability phenylephrine liquid compositions |
| US9005652B2 (en) | 2006-07-25 | 2015-04-14 | Wyeth | Chewable tablet containing phenylephrine |
| US9833510B2 (en) * | 2007-06-12 | 2017-12-05 | Johnson & Johnson Consumer Inc. | Modified release solid or semi-solid dosage forms |
| US9078824B2 (en) | 2007-09-24 | 2015-07-14 | The Procter & Gamble Company | Composition and method of stabilized sensitive ingredient |
| US8162276B2 (en) | 2008-09-29 | 2012-04-24 | Clipsy, Llc | Rotary joint assembly and combination clip-hook and jewelry piece employing the same |
| WO2010078542A1 (en) | 2009-01-05 | 2010-07-08 | Mcneil-Ppc, Inc. | Three layer tablet containing cetirizine, pseudoephedrine, and naproxen |
| WO2010078541A1 (en) * | 2009-01-05 | 2010-07-08 | Mcneil-Ppc, Inc. | Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen |
| RU2605299C2 (ru) * | 2011-02-14 | 2016-12-20 | Дзе Проктер Энд Гэмбл Компани | Твердая единица дозирования в пленочной оболочке, содержащей мед |
| US9770514B2 (en) | 2013-09-03 | 2017-09-26 | ExxPharma Therapeutics LLC | Tamper-resistant pharmaceutical dosage forms |
| GB201506755D0 (en) * | 2015-04-21 | 2015-06-03 | Reckitt Benckiser Llc | Novel pharmaceutical formulation |
| US11278506B2 (en) | 2015-10-09 | 2022-03-22 | Rb Health (Us) Llc | Pharmaceutical formulation |
| CA3038263C (en) | 2016-09-26 | 2022-04-05 | The Procter & Gamble Company | Extended relief dosage form |
-
2017
- 2017-09-25 CA CA3038263A patent/CA3038263C/en active Active
- 2017-09-25 US US15/713,746 patent/US10576041B2/en active Active
- 2017-09-25 CN CN201780059354.5A patent/CN109789101A/zh active Pending
- 2017-09-25 BR BR112019005224A patent/BR112019005224A2/pt not_active Application Discontinuation
- 2017-09-25 WO PCT/US2017/053157 patent/WO2018058009A1/en not_active Ceased
- 2017-09-25 RU RU2019109695A patent/RU2019109695A/ru unknown
- 2017-09-25 EP EP17778156.4A patent/EP3515413B1/en active Active
- 2017-09-25 MX MX2019003039A patent/MX385881B/es unknown
- 2017-09-25 AU AU2017331369A patent/AU2017331369B2/en active Active
- 2017-09-25 PL PL17778156.4T patent/PL3515413T3/pl unknown
-
2019
- 2019-12-16 US US16/714,856 patent/US11433030B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3515413B1 (en) | 2023-08-16 |
| WO2018058009A1 (en) | 2018-03-29 |
| US11433030B2 (en) | 2022-09-06 |
| MX385881B (es) | 2025-03-18 |
| MX2019003039A (es) | 2019-07-08 |
| EP3515413A1 (en) | 2019-07-31 |
| CA3038263C (en) | 2022-04-05 |
| CN109789101A (zh) | 2019-05-21 |
| CA3038263A1 (en) | 2018-03-29 |
| US10576041B2 (en) | 2020-03-03 |
| RU2019109695A3 (pl) | 2020-10-26 |
| US20180085317A1 (en) | 2018-03-29 |
| RU2019109695A (ru) | 2020-10-26 |
| AU2017331369A1 (en) | 2019-02-21 |
| AU2017331369B2 (en) | 2019-11-21 |
| BR112019005224A2 (pt) | 2019-06-11 |
| US20200113841A1 (en) | 2020-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIC20240013I1 (fi) | Lebrikitsumabi | |
| EP3463464A4 (en) | ASSOCIATION TREATMENT | |
| SI3529248T1 (sl) | Farmacevtske spojine | |
| DK3265421T3 (da) | Doseringssystem | |
| EP3291824A4 (en) | ANTIMICROBIAL THERAPY | |
| EP3552106A4 (en) | REDUCTION CALCULATION PROTOCOL | |
| EP3513809A4 (en) | MEDICAL COMPOSITION | |
| DK3310231T3 (da) | Doseringsindretning | |
| DK3356313T3 (da) | 2-perfluorhexyloktan til oftalmisk indgivelse | |
| PL3423087T3 (pl) | Skojarzona terapia przeciwnowotworowa | |
| BR112017027227A2 (pt) | Agente anti-câncer | |
| PL3484451T3 (pl) | Postać dawkowana | |
| DK3529240T3 (da) | Farmaceutiske forbindelser | |
| EP3424940A4 (en) | Radiolabeled drug | |
| DK3463345T3 (da) | Farmaceutiske kombinationer | |
| SMT202200173T1 (it) | Composti | |
| EP3307268A4 (en) | SUBSTITUTED PHENYLOXAZOLIDINONE FOR ANTIMICROBIAL THERAPY | |
| DK3359555T3 (da) | Doseringsplaner | |
| BR112017014839A2 (pt) | novos microbicidas | |
| EP3437644A4 (en) | MEDICINE | |
| IL262851A (en) | Combination prime: boost therapy | |
| DK3393478T3 (da) | Kombinationsterapi | |
| LT3383385T (lt) | Melflufeno dozavimo režimas vėžio atveju | |
| EP3362091A4 (en) | COMBINATION THERAPY | |
| DK3126791T3 (da) | Doseringsanordning |